Improving probiotic function using a pathobiotechnology approach

Gene Therapy and Molecular Biology

Volumn 11, Issue 2, 2007, Pages 269-274

  Sleator, Roy D ^a   Hill, Colin ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Betaine; BetL; Bifidobacterium; Lactobacillus; Listeria monocytogenes; Patho biotechnology; Probiotics

Indexed keywords

BIFIDOBACTERIUM; LACTOBACILLUS; LISTERIA MONOCYTOGENES;

EID: 41449111439     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Chang TL-Y, Chang CH, Simpson DA, Xu Q, Martin PK, Lagenaur LA, Schoolnik GK Ho DD, Hillier SL, Holodniy M, Lewicki JA, LeE PP (2003) Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci USA 100, 11672-7.
2. Claesson MJ, Li Y, Leahy S, Canchaya C, van Pijkeren JP, Cerdeño-Tárraga AM, Parkhill J Flynn S, O'Sullivan GC, Collins JK, Higgins D, Shanahan F, Fitzgerald GF, van Sinderen D and O'Toole PW ( 2006) Multireplicon genome architecture of Lactobacillus salivarius. Proc Natl Acad Sci USA 103, 6718-6723.
3. Dietrich G, Viret JF and Gentschev I (2003) Haemolysin A and listeriolysin - two vaccine delivery tools for the induction of cell-mediated immunity. Int J Parasitol 33, 495-505.
4. Guimarães VD, Gabriel JE, Lefèvre F, Cabanes D, Gruss A, Cossart P, Azevedo V, Langella P (2005) Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect 7, 836-844.
5. Hill C, Cotter P, Sleator RD, Gahan CGM (2002) Bacterial stress response in Listeria monocytogenes: jumping the hurdles imposed by minimal processing. Int Dairy J 12, 273-283.
6. Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11, S45-53.
7. Laurel AL, Berger EA (2005) An anti-HIV microbicide comes alive Proc Natl Acad Sci USA 102, 12294-12295.
8. Maa YF and Prestrelski SJ (2000) Biopharmaceutical powders: particle formation and formulation considerations. Curr Pharm Biotechnol 1, 283-302.
9. Paton AW, Morona R, Paton JC (2000) A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat Med 6, 265-270.
10. Paton AW, Morona R, Paton JC (2001) Neutralization of shiga toxins Stx1, Stx2c and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect Immun 69, 1967-1970.
11. Paton AW, Jennings MP, Morona R, Wang H, Focareta A, Roddam LF, Paton JC (2005) Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 128, 1219-28.
12. Paton A W, Morona R, Paton JC (2006) Designer probiotics for prevention of enteric infections. Nat Rev Microbiol 4, 193-200.
13. Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, Fekete RA, Kar S, Adhya S, Hamer DH (2005) Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci USA 102, 11993-11998.
14. Roland KL, Tinge SA, Killeen KP and Kochi SK (2005) Recent advances in the development of live, attenuated bacterial vectors. Curr Opin Mol Ther 7, 62-72.
15. Shahidi F and Han XQ (1993) Encapsulation of food ingredients. Crit Rev Food Sci Nutr 33, 501-547.
16. Sheehan VM, Sleator RD, Fitzgerald GF and Hill C (2006) Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl Environ Microbiol 72, 2170-2177.
17. Sheehan V, Sleator RD, Fitzgerald G and Hill C (2007) Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiol 153, 3563-3571.
18. Sleator RD, Gahan CGM, Abee T and Hill C (1999) Identification and disruption of BetL, a secondary glycine betaine transport system linked to the salt tolerance of Listeria monocytogenes LO28. Appl Environl Microbiol 65, 2078-2083.
19. Sleator RD, Gahan CGM, O'Driscoll B and Hill C (2000) Analysis of the role of betL in contributing to the growth and survival of Listeria monocytogenes LO28. Int J Food Microbiol 60, 261-268.
20. Sleator RD, Gahan CGM, Abee T, Wouters JA and Hill C. (2001). Analysis of the role of OpuC, an osmolyte transport system, in salt tolerance and virulence potential of Listeria monocytogenes. Appl. Environ. Microbiol 67, 2692-2698.
21. Sleator RD and Hill C (2002) Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence. FEMS Microbiol Rev 26, 49-71.
22. Sleator RD, Gahan CGM and Hill C (2003a) A post-genomic appraisal of osmotolerance in Listeria monocytogenes. Appl Environl Microbiol 69, 1-9.
23. Sleator RD, Wood JM and Hill C (2003b) Transcriptional regulation and post-translational activity of the betaine transporter BetL in Listeria monocytogenes is controlled by environmental salinity. J Bacteriol 185, 7140-7144.
24. Sleator RD, and Hill C (2006) Patho-biotechnology; using bad bugs to do good things. Curr Opin Biotech 17, 211-216.
25. Sleator RD and Hill C (2007a) 'Bioengineered bugs' - A pathobiotechnology approach to probiotic research and applications. Med Hypotheses doi:10.1016/j.mehy.2007.03.008.
26. Sleator RD and Hill C (2007b) Probiotics as therapeutics for the developing world. J Infect Develop Countries 1, 7-12.
27. Smiddy M, Sleator RD, Patterson MF, C Hill and AL Kelly (2004) Role for compatible solutes glycine betaine and L-carnitine in listerial barotolerance. Appl Environ Microbiol 70, 7555-7557.
28. Smiddy M, O'Gorman L, Sleator RD, Hill C and Kelly A (2005) Greater high-pressure resistance of bacteria in oysters than in broth. Inn Food Sci Emerg Tech 6, 83-90.
29. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21, 785-9.
30. Termont S, Vandenbroucke K, Iserentant D, Neirynck S, Steidler L, Remaut E and Rottiers P (2006) Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance. Appl Environ Microbiol 72, 7694-7700.
31. Torres B, Jaenecke S, Timmis KN, Garcia JL, Diaz E (2003) A dual lethal system to enhance containment of recombinant micro-organisms. Microbiol 149, 3595-3601.